Clinical application of sparse canonical correlation analysis to detect genetic associations with cortical thickness in Alzheimer's disease

Front Neurosci. 2024 Sep 24:18:1428900. doi: 10.3389/fnins.2024.1428900. eCollection 2024.

Abstract

Introduction: Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by cerebral cortex atrophy. In this study, we used sparse canonical correlation analysis (SCCA) to identify associations between single nucleotide polymorphisms (SNPs) and cortical thickness in the Korean population. We also investigated the role of the SNPs in neurological outcomes, including neurodegeneration and cognitive dysfunction.

Methods: We recruited 1125 Korean participants who underwent neuropsychological testing, brain magnetic resonance imaging, positron emission tomography, and microarray genotyping. We performed group-wise SCCA in Aβ negative (-) and Aβ positive (+) groups. In addition, we performed mediation, expression quantitative trait loci, and pathway analyses to determine the functional role of the SNPs.

Results: We identified SNPs related to cortical thickness using SCCA in Aβ negative and positive groups and identified SNPs that improve the prediction performance of cognitive impairments. Among them, rs9270580 was associated with cortical thickness by mediating Aβ uptake, and three SNPs (rs2271920, rs6859, rs9270580) were associated with the regulation of CHRNA2, NECTIN2, and HLA genes.

Conclusion: Our findings suggest that SNPs potentially contribute to cortical thickness in AD, which in turn leads to worse clinical outcomes. Our findings contribute to the understanding of the genetic architecture underlying cortical atrophy and its relationship with AD.

Keywords: Alzheimer’s disease; amyloid beta (Ab); cortical thickness; genetics; single nucleotide polymorphism (SNP); sparse canonical correlation analysis.

Grants and funding

The authors declare that they received financial support for the research, authorship, and publication of this article. This work was partly supported by an Institute of Information and Communications Technology Planning and Evaluation (IITP) grant funded by the Korean government (MSIT) [No. 2019-0-01842, Artificial Intelligence Graduate School Program (GIST); No. RS-2021-II212068, Artificial Intelligence Innovation Hub] and the National Research Foundation of Korea under grant NRF-2022R1F1A1068529, Future Medicine 2030 Project of the Samsung Medical Center (#SMX1240011), National Research Foundation of Korea(NRF) grant funded by the Korea government (MSIT) (No. RS-2023-00247408), and Korea Dementia Research Project through the Korea Dementia Research Center (KDRC), funded by the Ministry of Health and Welfare and Ministry of Science and ICT, Republic of Korea (grant number: RS-2020-KH106434).